Newsweek: Have the Jan.6 hearings hurt Donald Trump?
UC political scientist David Niven cited in national media on review of Jan. 6 hearings
In an analysis of the Jan. 6 committee hearings, Newsweek summarizes public interest in the hearings and what the fallout might be for Trump.
The article reports that the first live primetime hearing on June 9 attracted 20 million viewers across the news networks, according to the Nielsen ratings. However, those numbers have started to fall, albeit with the subsequent hearings not being played in primetime slots.
UC’s David Niven, an associate professor in the School of Public and International Affairs, was among the experts cited in the article.
“Ironically, one of Trump's great political strengths is that there are so many things wrong with him that it is hard to hold people's focus on just one thing for any length of time," Niven told Newsweek.
The hearings in and of themselves might not get the best ratings, but what matters is if the committee persuades the Department of Justice that Trump committed a number of crimes during his attempts to overturn the election results in the run-up to the January 6 attack.
Each session, Niven said, “is a reminder that Trump lied, Trump connived, and ultimately, Trump unleashed a torrent of violence against innocent people trying to lawfully do their jobs."
Niven is an often-cited expert on American politics. His research focus is on political campaigns, gerrymandering, political communication and death penalty policy.
UC’s School of Public and International Affairs was created out of the former Department of Political Science, which dates to 1914. Experts from the school are regularly cited in national and international media outlets.
Featured image courtesy of Unsplash.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
Meet the young talent reshaping Cincinnati’s startup scene
October 28, 2025
Five University of Cincinnati students were honored for their impactful entrepreneurship on the Cincy Inno Under 25 list. We’ll explain what makes each student – and their startup – stand out.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.